近日，中慧生物 ...

BioNTechSE的创始人将离开公司，创立一家专注于信使RNA（mRNA）技术的新生物技术公司，该技术正是其爆款新冠疫苗的核心技术。 BioNTech周二表示，乌古尔・萨欣与厄兹勒姆・图雷西这对夫妇将于年底前加入新公司。该公司的美国存托凭证（ADR）在盘前交易中一度暴跌21%。 在这一关键节点，联合投资公司投资组合经理、同时也是BioNTech投资者的马库斯・曼斯表示：“公司创始人的离去，对企业 ...

智通财经APP获悉，在周二美股盘后交易中，mRNA疫苗领域领军者Moderna (MRNA.US)股价一度大幅上涨超11%，此前该生物科技领军者与Arbutus Biopharma(ABUS.US)和Genevant Sciences(ROIV.US ...

In the latest trading session, Moderna (MRNA) closed at $49.20, marking a -1.66% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.11%. On the other hand, ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving from 1.90% in May to 1.96%, indicating a collective rise in negative bets ...

Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak. When I wrote about the Moderna stock setup last week, shares sat around $50. Today they’ve nudged back to about $53 — but ...

Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 across the United States, European Union, Canada and Australia. These filings ...

The S&P 500 Healthcare sector (XLV) experienced a slight rise in average short interest during October, moving from 1.91% to 2.00%. Within this sector, Moderna (MRNA) remains the most heavily shorted ...

Moderna (MRNA) stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return. The company’s value has increased by approximately $1.2 billion over ...

CHONGQING, CHINA - FEBRUARY 3: In this photo illustration, a smartphone displays the logo of Moderna, Inc. (NASDAQ: MRNA), a U.S.-based biotechnology company specializing in messenger RNA (mRNA) ...

Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization to ...